Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO
2022-09-05 22:39
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US
2022-09-05 21:09
Lunit to Showcase 5 Abstracts at ESMO 2022
2022-09-05 21:00
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives
2022-09-05 16:00
Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue
2022-09-05 13:09
Tamas Oravecz Ph.D. named SVP, CSO of the U.S. of Simcere Pharmaceutical Group
2022-09-05 13:08
New Building Stands as Symbol of Dignity and Hope For Persons Affected by Leprosy in Ethiopia
2022-09-02 22:00
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products
2022-09-02 20:50
Waterdrop Inc. to Report Second Quarter 2022 Financial Results on September 9, 2022
2022-09-02 20:00
Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China
2022-09-02 19:00
Jacobio Completes First Dose of IIa Clinical Trial of JAB-21822 on KRAS G12C and STK11 Co-mutation in China
2022-09-02 17:14
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022
2022-09-02 09:41
Pxierra is launching world's first non-contact heart rate & breathe rate measurement AI baby monitor
2022-09-01 21:00
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management
2022-09-01 19:30
The ECO-Friendly Anti-nausea and Vomiting wristband: Emeterm PLUS
2022-09-01 01:15
AI Startup AESOP Raises $3M to Tackle Medical and Billing Errors
2022-09-01 00:00
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey
2022-08-31 20:00
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
2022-08-31 17:05
Nreal Air AR Glasses Receive TÜV Rheinland Eye Comfort (AR) Certification
2022-08-31 10:27
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance
2022-08-31 08:33
1
140
141
142
143
144
812